Opening of AI-powered National Distribution Centre

Further to its announcement on 1 October 2025 regarding the acquisition of key assets from Universal Pharmacy Limited (in administration) ("Universal"), Medpal (AIM:MPAL), is pleased to announce the opening of a distribution centre at Ecotech Business Park, Swaffham (the "Centre").

Included in the assets acquired by the Company's wholly owned subsidiary Medpal Limited from Universal was a Distance Selling Pharmacy (DSP) licence enabling nationwide distribution of medication and a warehouse unit at the Centre. The UK pharmacy regulator, the General Pharmaceutical Council ("GPhC"), ceased issuing new DSP licences in June 2025. Using some of the proceeds of the placing and retail offer also announced on 1 October 2025, Medpal Limited has acquired advanced robotic dispensing equipment and leased two adjacent units, tripling the size of the original facility to create a state-of-the-art, 24/7 automated medicines fulfilment hub, which will be integrated with AI to enable the delivery of over 100,000 prescriptions per month.

Access to the pharmacy service will be advertised nationally and via the Company's MedPal app. At any time of day or night, users of the service will be able to complete an AI-supported consultation, which will produce a recommendation for a prescription, which will be signed off by a qualified Independent Prescriber ("IP") or General Practitioner ("GP") and then fulfilled at the Centre, which, being entirely automated, operates 24 hours a day. Medication will then be delivered to the user either the same or next day. There will be no charge to the user for the consultation or prescription, only for the medication.

Highlights

• Tripled footprint at Ecotech Business Park to support national scale, resilience and extended hours.
• Automation-led operations: installation of an Omnicell VBM and a BD Rowa VMAX advanced robotic dispensing system to increase throughput, accuracy and cost efficiency.
• AI-enabled triage: MedPal Limited's AI triage routes users to appropriate care, with instant access to independent prescribers and GPs, providing oversight and issuing prescriptions where clinically appropriate.
• Faster access to treatment: launch of same-day and next-day delivery services for eligible prescription medicines, including weight-loss treatments and other therapies, subject to prescription and clinical suitability.
• 24/7 capability: continuous intake, verification and automated dispensing to improve service levels for both private and NHS prescriptions.

Revolutionising Primary Care Through AI and Robotics

The Centre brings together MedPal's "digital front door" (including the MedPal app) and advanced robotic dispensing, delivering a vertically integrated, low-cost, high-reliability fulfilment model.

The expanded facility is designed to:

• increase access to primary-care pathways by providing rapid digital assessment and streamlined prescribing;
• lower unit costs through automation, enabling competitive pricing and improved patient affordability;
• enhance safety and quality via barcoded workflows, machine vision checks and pharmacist oversight; and
• support growth in both direct-to-consumer private prescriptions and NHS prescription supply for community patients.

The Centre will initially focus on high-demand services including weight loss medications, and chronic disease management prescriptions with same-day delivery capability in key metropolitan areas and next-day delivery nationwide. The 24/7 operational model addresses the growing demand for telehealth services, particularly among working-age patients unable to access traditional GP surgeries during business hours.

At the heart of this development is the integration of MedPal's proprietary AI triage system with state-of-the-art robotic dispensing technology, which leverages AI and robotics to reduce dispensing errors, optimise inventory, and scale services to meet growing demand. This synergy allows MedPal app users to access telemedicine and telehealth services, optimising speed and affordability, making primary care available instantly and affordably, facilitating better health outcomes than conventional processes where users frequently encounter accessibility challenges such as delays and/or high costs.

Jason Drummond, CEO of MedPal AI commented:

"This distribution centre represents a milestone in our mission to democratise healthcare. By combining our Medpal AI triage with robotic innovation, we are creating a 24/7 ecosystem that makes primary care accessible and affordable, while always prioritising patient safety through human expertise and oversight."